Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

KARI E NARGOSKI

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1124322573
CMS profile
10874680
Location
SWOYERSVILLE, PA

General Payments · PY2021–2024

$328.17

  • Reported across 23 records
  • CMS publication 2026-06-30

Latest program year · PY2024

$215.23

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $215.23 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $137.30 12
Phathom Pharmaceuticals, Inc. $40.88 2
Abbott Laboratories $21.66 1
ABBVIE INC. $15.39 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $64.82 4
PY2022 $31.08 2
PY2023 $17.04 1
PY2024 $215.23 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $21.66 06/27/2024 Food and Beverage Undisputed 06/30/2026 1124857221 CMS
ABBVIE INC. $15.39 05/22/2024 Food and Beverage Undisputed 06/30/2026 1107720116 CMS
Novo Nordisk Inc $7.56 01/30/2024 Food and Beverage Undisputed 06/30/2026 1100334204 CMS
Novo Nordisk Inc $8.79 03/13/2024 Food and Beverage Undisputed 06/30/2026 1100593028 CMS
Novo Nordisk Inc $20.61 05/23/2024 Food and Beverage Undisputed 06/30/2026 1100428351 CMS
Novo Nordisk Inc $5.00 06/05/2024 Food and Beverage Undisputed 06/30/2026 1100628600 CMS
Novo Nordisk Inc $7.30 06/18/2024 Food and Beverage Undisputed 06/30/2026 1100355414 CMS
Novo Nordisk Inc $20.88 07/17/2024 Food and Beverage Undisputed 06/30/2026 1100645643 CMS
Novo Nordisk Inc $21.89 08/14/2024 Food and Beverage Undisputed 06/30/2026 1100636831 CMS
Novo Nordisk Inc $7.12 08/27/2024 Food and Beverage Undisputed 06/30/2026 1100540302 CMS
Novo Nordisk Inc $7.44 09/17/2024 Food and Beverage Undisputed 06/30/2026 1100427194 CMS
Novo Nordisk Inc $22.37 10/09/2024 Food and Beverage Undisputed 06/30/2026 1100490539 CMS
Novo Nordisk Inc $7.81 11/27/2024 Food and Beverage Undisputed 06/30/2026 1100628590 CMS
Novo Nordisk Inc $0.53 11/27/2024 Food and Beverage Undisputed 06/30/2026 1100654363 CMS
Phathom Pharmaceuticals, Inc. $26.68 05/07/2024 Food and Beverage Undisputed 06/30/2026 1151192081 CMS
Phathom Pharmaceuticals, Inc. $14.20 06/05/2024 Food and Beverage Undisputed 06/30/2026 1151192083 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.